The use of antimicrobials over the past six decades has been associated with the emergence and dissemination of antimicrobial-resistant bacteria. To explore local geographical patterns in the occurrence of acquired antimicrobial resistance (AMR), AMR of E. coli causing urinary tract infections (UTI) in the community in the West of Ireland was mapped. All adult patients consulting with a suspected UTI in 22 general practices in the West of Ireland over a nine-month study period were requested to supply a urine sample. Those with a laboratory confirmed E. coli infection were included ( n = 752) in the study. Antimicrobial susceptibility testing was performed by standardized disc diffusion. Patient addresses were geocoded. The diameters of the zone of inhibition of growth for trimethoprim (5 μg) and ciprofloxacin (5 μg) for the relevant isolate was mapped against the patient address using ArcGIS software. A series of maps illustrating spatial distribution of AMR in the West of Ireland were generated. The spatial data demonstrated a higher proportion of isolates with AMR from urban areas. Some rural areas also showed high levels of resistant E. coli. Our study is the first to demonstrate the feasibility of using a geographical information system (GIS) platform for routine visual geographical analysis of AMR data in Ireland. Routine presentation of AMR data in this format may be valuable in understanding AMR trends at a local level.
References
[1]
Wise, R.; Hart, T.; Cars, O.; Streulens, M.; Helmuth, R.; Huovinen, P.; Sprenger, M. Antimicrobial resistance is a major threat to public health. Br. Med. J. 1998, 317, 609–610, doi:10.1136/bmj.317.7159.609.
[2]
Cormican, M.; Vellinga, A. Existing classes of antibiotics are probably the best we will ever have. Br. Med. J. 2012, 344, e3369, doi:10.1136/bmj.e3369.
[3]
Vellinga, A.; Tansey, S.; Hanahoe, B.; Bennett, K.; Murphy, A.W.; Cormican, M. Trimethoprim and ciprofloxacin resistance and prescribing in urinary tract infection associated with Escherichia coli: A multilevel model. J. Antimicrob. Chemother. 2012, 67, 2523–2530.
[4]
Sannes, M.R.; Kuskowski, M.A.; Johnson, J.R. Geographical distribution of antimicrobial resistance among Escherichia coli causing acute uncomplicated pyelonephritis in the united states. FEMS Immunol. Med. Microbiol. 2004, 42, 213–218, doi:10.1016/j.femsim.2004.05.004.
[5]
McCormick, A.W.; Whitney, C.G.; Farley, M.M.; Lynfield, R.; Harrison, L.H.; Bennett, N.M.; Schaffner, W.; Reingold, A.; Hadler, J.; Cieslak, P.; et al. Geographic diversity and temporal trends of antimicrobial resistance in Streptococcus pneumoniae in the united states. Nat. Med. 2003, 9, 424–430.
[6]
Kalter, H.D.; Gilman, R.H.; Moulton, L.H.; Cullotta, A.R.; Cabrera, L.; Velapatino, B. Risk factors for antibiotic-resistant Escherichia coli carriage in young children in Peru: Community-based cross-sectional prevalence study. Am. J. Trop. Med. Hyg. 2010, 82, 879–888.
[7]
Magee, J.T.; Heginbothom, M.L.; Mason, B.W. Finding a strategy: The case for co-operative research on resistance epidemiology. J. Antimicrob. Chemother. 2005, 55, 628–633, doi:10.1093/jac/dki077.
[8]
Lipsitch, M.; Samore, M.H. Antimicrobial use and antimicrobial resistance: A population perspective. Emerg. Infect. Dis. 2002, 8, 347–354.
[9]
ECDC Ears-net Database. Available online: http://ecdc.europa.eu/en/activities/surveillance/EARS-net/database/Pages/database.aspx (accessed on 5 April 2013).
[10]
European Surveillance of Antimicrobial Consumption (ESAC) database. Available online: http://app.esac.ua.ac.be/public/ (accessed on 5 April 2013).
[11]
Carey, B.; Murphy, M.; Bradley, C.; Cunney, R.; Byrne, S.; O’Connor, N.; Sheehan, A. Guidelines for Antimicrobial Prescribing in Primary Care in Ireland; Health Protection Surveillance Centre: Dublin, Ireland, 2011; p. 24.
[12]
Perez-Trallero, E.; Garcia-de-la-Fuente, C.; Garcia-Rey, C.; Baquero, F.; Aguilar, L.; Dal-Re, R.; Garcia-de-Lomas, J. Spanish surveillance group for respiratory, geographical and ecological analysis of resistance, coresistance, and coupled resistance to antimicrobials in respiratory pathogenic bacteria in spain. Antimicrob. Agents Chemother. 2005, 49, 1965–1972, doi:10.1128/AAC.49.5.1965-1972.2005.
[13]
Samore, M.H.; Magill, M.K.; Alder, S.C.; Severina, E.; Morrison-De Boer, L.; Lyon, J.L.; Carroll, K.; Leary, J.; Stone, M.B.; Bradford, D.; et al. High rates of multiple antibiotic resistance in Streptococcus pneumoniae from healthy children living in isolated rural communities: Association with cephalosporin use and intrafamilial transmission. Pediatrics 2001, 108, 856–865, doi:10.1542/peds.108.4.856.
[14]
Carmeli, Y.; Castro, J.; Eliopoulos, G.M.; Samore, M.H. Clinical isolation and resistance patterns of and superinfection with 10 nosocomial pathogens after treatment with ceftriaxone versus ampicillin-sulbactam. Antimicrob. Agents Chemother. 2001, 45, 275–279, doi:10.1128/AAC.45.1.275-279.2001.
[15]
Masiero, G.; Filippini, M.; Ferech, M.; Goossens, H. Socioeconomic determinants of outpatient antibiotic use in Europe. Int. J. Public Health. 2010, 55, 469–478, doi:10.1007/s00038-010-0167-y.
[16]
Samarasundera, E.; Walsh, T.; Cheng, T.; Koenig, A.; Jattansingh, K.; Dawe, A.; Soljak, M. Methods and tools for geographical mapping and analysis in primary health care. Prim. Health Care Res. Dev. 2012, 13, 10–21, doi:10.1017/S1463423611000417.
[17]
Noble, D.; Smith, D.; Mathur, R.; Robson, J.; Greenhalgh, T. Feasibility study of geospatial mapping of chronic disease risk to inform public health commissioning. Br. Med. J. Open 2012, 2, e000711.
[18]
Callaghan, M.; Cormican, M.; Prendergast, M.; Pelly, H.; Cloughley, R.; Hanahoe, B.; O'Donovan, D. Temporal and spatial distribution of human cryptosporidiosis in the west of ireland 2004–2007. Int. J. Health Geogr. 2009, 8, e64, doi:10.1186/1476-072X-8-64.
[19]
McGrath, G.; Abernethy, D.; Stringer, L.; More, S. An all-island approach to mapping bovine tuberculosis in ireland. Irish Vet. J. 2009, 62, 192–197.
[20]
Tirabassi, M.V.; Wadie, G.; Moriarty, K.P.; Garb, J.; Konefal, S.H.; Courtney, R.A.; Sachs, B.F.; Wait, R. Geographic information system localization of community-acquired MRSA soft tissue abscesses. J. Ped. Surg. 2005, 40, 962–965; discussion 965–966, doi:10.1016/j.jpedsurg.2005.03.010.
[21]
Mouro, A.; Kiffer, C.; Koga, P.C.; Monteiro, A.M.; Camargo, E.C.; Pignatari, A.C. Spatial exploration of Streptococcus pneumoniae clonal clustering in Sao Paulo, Brazil. Braz. J. Infect. Dis. 2011, 15, 462–466, doi:10.1016/S1413-8670(11)70228-8.
[22]
Kiffer, C.R.; Camargo, E.C.; Shimakura, S.E.; Ribeiro, P.J., Jr.; Bailey, T.C.; Pignatari, A.C.; Monteiro, A.M. A spatial approach for the epidemiology of antibiotic use and resistance in community-based studies: The emergence of urban clusters of Escherichia coli quinolone resistance in Sao Paulo, Brasil. Int. J. Health Geogr. 2011, 10, e17.
[23]
Vellinga, A.; Cormican, M.; Hanahoe, B.; Bennett, K.; Murphy, A.W. Antimicrobial management and appropriateness of treatment of urinary tract infection in general practice in ireland. BMC Fam Pract. 2011, 12, e108, doi:10.1186/1471-2296-12-108.
[24]
Vellinga, A.; Cormican, M.; Hanahoe, B.; Bennett, K.; Murphy, A.W. Opt-out as an acceptable method of obtaining consent in medical research: A short report. BMC Med. Res. Meth. 2011, 11, e40, doi:10.1186/1471-2288-11-40.
[25]
Central Statistics Office. Available online: http://www.cso.ie/en/index.html (accessed on 6 February 2013).
[26]
European Committee on Antimicrobial Susceptibility Testing (EUCAST) Clinical breakpoints. Available online: http://www.eucast.org/clinical_breakpoints/ (accessed on 15 September 2012).
